Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism
- 15 April 1999
- journal article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 18 (15), 2471-2479
- https://doi.org/10.1038/sj.onc.1202600
Abstract
IGF-II, produced by breast cancer epithelial and stromal cells, enhances tumor growth by activating the IGF-I receptor (IGF-I-R) via autocrine and paracrine mechanisms. Previously we found that the insulin receptor (IR), which is related to the IGF-I-R, is overexpressed in breast cancer cells. Herein, we find that, in breast cancer the IR is activated by IGF-II. In eight human breast cancer cell lines studied there was high affinity IGF-II binding to the IR, with subsequent IR activation. In these lines, IGF-II had a potency up to 63% that of insulin. In contrast, in non malignant human breast cells, IGF-II was less than 1% potent as insulin. Via activation of the IR tyrosine kinase IGF-II stimulated breast cancer cell growth. Moreover, IGF-II also activated the IR in breast cancer tissue specimens; IGF-II was 10-100% as potent as insulin. The IR occurs in two isoforms generated by alternative splicing of exon 11; these isoforms are IR-A (Ex11-) and IR-B (Ex11+). IR-A was predominantly expressed in breast cancer cells and specimens and the potency of IGF-II was correlated to the expression of this isoform (P<0.0001). These data indicate, therefore, that the IR-A, which binds IGF-II with high affinity, is predominantly expressed in breast cancer cells and represents a new autocrine/paracrine loop involved in tumor biology.Keywords
This publication has 20 references indexed in Scilit:
- Growth-Promoting Interaction of IGF-II with the Insulin Receptor during Mouse Embryonic DevelopmentDevelopmental Biology, 1997
- Growth Factors in Breast CancerEndocrine Reviews, 1995
- Insulin receptor overexpression in 184B5 human mammary epithelial cells induces a ligand‐dependent transformed phenotypeJournal of Cellular Biochemistry, 1995
- Characterization of new monoclonal antibodies to human insulin-like growth factor-II and their application in western immunoblot analysis.Journal of Clinical Endocrinology & Metabolism, 1993
- High-affinity insulin binding to an atypical insulin-like growth factor-I receptor in human breast cancer cells.JCI Insight, 1992
- ELECTROCHEMICAL MEASUREMENT OF HYDROGEN PERMEATED THROUGH STEEL AT HIGH TEMPERATURE USING A CERAMIC SENSORPublished by Elsevier BV ,1992
- Overexpression of Insulin Receptors in Fibroblast and Ovary Cells Induces a Ligand-Mediated Transformed PhenotypeMolecular Endocrinology, 1991
- Elevated insulin receptor content in human breast cancer.JCI Insight, 1990
- Insulin-Like Growth Factor-ll (IGF-II): A Potential Autocrine/Paracrine Growth Factor for Human Breast Cancer Acting via the IGF-I ReceptorMolecular Endocrinology, 1989
- The human insulin receptor cDNA: The structural basis for hormone-activated transmembrane signallingCell, 1985